Mycoplasma Testing Market is poised to grow from USD 867.72 Million in 2024 to USD 1834.48 Million by 2032, at a CAGR of 9.81% during the forecast period from 2025 to 2032, driven by rising investments in biotechnology research and increasing demand for high-quality biologic products.
Comments
0 comment